Research & Validation
Our technology pipeline is grounded in scientific validation originating from the University of Pennsylvania. Every program follows a stage-gated development process from discovery through commercialization.
Commercialization Pipeline
Human Therapeutics
Animal Health & Agriculture
Industrial & Environmental Enzymes
Selected Publications
Our platform is built upon decades of peer-reviewed research, led by Prof. Henry Daniell at the University of Pennsylvania.
Plant-made FRIL as a broad-spectrum antiviral agent
Demonstrates the efficacy of plant-produced FRIL in neutralizing multiple strains of SARS-CoV-2 by binding to complex glycans on the viral spike protein.
Oral delivery of bioencapsulated therapeutic proteins
Validation of the chloroplast transformation method for protecting therapeutic proteins through the digestive tract.
Scalable production of enzymes in leafy biomass
Establishes the cost-efficiency and high-yield expression of industrial enzymes directly in plant chloroplasts.
Mucosal immunity induced by plant-based antigens
Foundational study showing that bioencapsulated proteins can successfully cross the gut epithelium and stimulate a robust immune response.
FRIL Bean Feed vs. H5N1
An interactive simulation demonstrating how the FRIL protein builds a biological shield within a hen's digestive tract, physically blocking and neutralizing the H5N1 Avian Influenza virus.